Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
1,129.82
988.00
894.07
860.15
615.63
281.14
278.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,129.82
988.00
894.07
860.15
615.63
281.14
278.14
Raw Material Cost
741.61
608.40
634.98
578.98
375.79
173.24
173.64
Purchase of Finished goods
58.35
84.89
63.15
60.25
101.54
0.00
0.00
(Increase) / Decrease In Stocks
-27.75
-11.69
-65.86
-26.58
-18.26
-1.44
-3.72
Employee Cost
75.26
61.15
52.05
47.66
25.54
19.53
17.54
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
0.01
0.00
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
142.59
114.43
88.43
85.56
49.99
36.01
40.05
Total Expenditure (Excl Depreciation)
990.05
857.18
772.76
745.87
534.60
227.34
227.52
Operating Profit (PBDIT) excl Other Income
139.77
130.82
121.31
114.28
81.03
53.80
50.62
Other Income
2.80
1.67
3.55
1.56
7.03
5.55
1.62
Operating Profit (PBDIT)
142.57
132.49
124.86
115.84
88.06
59.35
52.24
Interest
11.82
7.37
11.35
13.30
2.56
1.83
1.67
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
130.75
125.12
113.51
102.54
85.50
57.52
50.57
Depreciation
35.98
30.53
29.23
30.96
16.51
9.38
7.84
Profit Before Tax
94.78
94.60
84.30
71.59
68.99
48.15
42.73
Tax
25.30
24.87
22.10
19.72
18.28
12.33
10.83
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
69.48
69.73
62.20
51.87
50.71
35.81
31.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
69.48
69.73
62.20
51.87
50.71
35.81
31.90
Share in Profit of Associates
0.99
0.50
-0.03
0.73
0.06
0.41
0.00
Minority Interest
0.00
0.00
0.00
0.00
-0.02
-0.03
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
70.47
70.23
62.17
52.60
50.75
36.19
31.90
Equity Capital
11.07
11.06
11.05
11.03
11.01
10.39
4.40
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
353.18
Earnings per share (EPS)
12.73
12.7
11.25
9.54
9.22
6.97
6.59
Diluted Earnings per share
12.74
12.69
11.24
9.49
9.29
7.02
6.59
Operating Profit Margin (Excl OI)
12.37%
13.24%
13.57%
13.29%
13.16%
19.14%
18.2%
Gross Profit Margin
11.57%
12.66%
12.7%
11.92%
13.89%
20.46%
18.18%
PAT Margin
6.24%
7.11%
6.95%
6.12%
8.25%
12.88%
11.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 14.35% vs 10.51% in Sep 2024
Consolidate Net Profit
Growth in half year ended Sep 2025 is 0.34% vs 12.96% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 6.84% vs 7.84% in Sep 2024
Interest
Growth in half year ended Sep 2025 is 60.38% vs -35.07% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has fallen from Sep 2024
Compare Half Yearly Results Of Rossari Biotech With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
1,129.82
240.38
889.44
370.01%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,129.82
240.38
889.44
370.01%
Raw Material Cost
741.61
125.88
615.73
489.14%
Purchase of Finished goods
58.35
2.53
55.82
2,206.32%
(Increase) / Decrease In Stocks
-27.75
-15.20
-12.55
-82.57%
Employee Cost
75.26
29.03
46.23
159.25%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
142.59
58.60
83.99
143.33%
Total Expenditure (Excl Depreciation)
990.05
200.84
789.21
392.95%
Operating Profit (PBDIT) excl Other Income
139.77
39.54
100.23
253.49%
Other Income
2.80
2.16
0.64
29.63%
Operating Profit (PBDIT)
142.57
41.70
100.87
241.89%
Interest
11.82
0.92
10.90
1,184.78%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
130.75
40.78
89.97
220.62%
Depreciation
35.98
18.02
17.96
99.67%
Profit Before Tax
94.78
22.76
72.02
316.43%
Tax
25.30
6.20
19.10
308.06%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
69.48
16.57
52.91
319.31%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
69.48
16.57
52.91
319.31%
Share in Profit of Associates
0.99
0.00
0.99
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
70.47
16.57
53.90
325.29%
Equity Capital
11.07
23.39
-12.32
-52.67%
Face Value
2.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.73
7.08
5.65
79.80%
Diluted Earnings per share
12.74
7.08
5.66
79.94%
Operating Profit Margin (Excl OI)
12.37%
16.45%
0.00
-4.08%
Gross Profit Margin
11.57%
16.96%
0.00
-5.39%
PAT Margin
6.24%
6.89%
0.00
-0.65%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 1,129.82 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 14.35% vs 10.51% in Sep 2024
Half Yearly - Consolidate Net Profit
Consolidate Net Profit 70.47 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 0.34% vs 12.96% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 139.77 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 6.84% vs 7.84% in Sep 2024
Half Yearly - Interest
Interest 11.82 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 60.38% vs -35.07% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.37%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has fallen from Sep 2024






